Werner Koopman, theme Mitochondrial diseases, received 400,000 euro as a member of the PD-MitoQUANT consortium. The latter is an EU-funded Innovative Medicines Initiative research project that will improve our understanding of Parkinson’s so that better treatments can be developed in the future.The project will run for three years, receiving 4.5 million euro in funding from the EU’s Horizon 2020 programme and 2.46 million euro in-kind from European Federation of Pharmaceutical Industries and Associations (EFPIA) members and Parkinson’s UK.
PD-MitoQUANT focuses on how mitochondria, the ‘powerhouses’ of the cell, contribute to cell death and neurodegeneration when they malfunction. The project involves 14 partners from 9 countries, including academic experts from the Royal College of Surgeons in Ireland, Institut du Cerveau et de la Moelle Epinière, German Center for Neurodegenerative Diseases, Neuroscience Institute of the National Research Council, University College London, Radboud University Medical Centre, the Centre National de la Recherche Scientifique, SMEs (GeneXplain GmbH, Mimetas, Pintail Limited), pharmaceutical companies (Teva Pharmaceutical Industries Ltd.; H. Lundbeck A/S; UCB S.A.), and a patient advocacy organization (Parkinson’s UK).
Innovative Medicines Initiative (IMI): link.
Related news items
Four Veni grants for young RIMLS researchers22 July 2019
Four young researchers, affiliated to the RIMLS, have each received a Veni grant of 250,000 Euro from NWO. Our researchers received this prestigious grant for their remarkable and original talent and their ability to carry out innovative research.read more
4,8 million euros for prevention of tuberculosis among people with diabetes in Africa16 July 2019
Reinout van Crevel and Lindsey te Brake have received European funding of 4.8 million euros to lead an international consortium to screen thousands of people with diabetes in Uganda and Tanzania for TB, and investigate the effect and costs of 3 months preventive treatment for TB.read more
Handbook of biomarkers and precision medicine a new publication by Alain van Gool12 July 2019
Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.read more
The real impact of menstrual complaints on work and school productivity8 July 2019
Menstrual period symptoms may be linked to nearly nine days of lost productivity every year, through presenteeism, suggests the largest study of its kind, published in the journal BMJ Open. But the real impact on women and society is underestimated and poorly appreciated, say the researchers.read more